N-acetylcysteine for the treatment of COVID-19 among hospitalized patients.

Avdeev, Sergey N; Gaynitdinova, Viliya V; Merzhoeva, Zamira M; Berikkhanov, Zelimkhan G-M

Avdeev, Sergey N; Gaynitdinova, Viliya V; Merzhoeva, Zamira M; Berikkhanov, Zelimkhan G-M.

Avdeev SN; Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. Electronic address: serg_avdeev@list.ru.
Gaynitdinova VV; Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Merzhoeva ZM; Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Berikkhanov ZG; Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

J Infect ; 84(1): 94-118, 2022 01.

Article in English | MEDLINE | ID: covidwho-1305269

Subject(s)

COVID-19; Hydrogen Sulfide; Acetylcysteine; Humans; SARS-CoV-2

Keywords

COVID-19; Hydrogen sulfide; N-acetylcysteine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hydrogen Sulfide Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google